Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

NCT00004464 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Aplastic Anemia
Paroxysmal Hemoglobinuria, Nocturnal

Interventions

DRUG: cyclophosphamide
DRUG: filgrastim

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins